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| INVESTIGATION
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in Caenorhabditis elegans by Gain of Function in
Extracellular Matrix and Cell-Matrix Attachment Genes
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Section of Cell and Developmental Biology, Division of Biological Sciences, University of California, San Diego,
La Jolla, California 92093
ORCID IDs: 0000-0002-7517-1256 (J.R.G.); 0000-0001-5091-0537 (A.D.C.)
ABSTRACT Basement membranes are extracellular matrices essential for embryonic development in animals. Peroxidasins are extracellular
peroxidases implicated in the unique sulfilimine cross-links between type IV basement membrane collagens. Loss of function in the
Caenorhabditis elegans peroxidasin PXN-2 results in fully penetrant embryonic or larval lethality. Using genetic suppressor screening, we
find that the requirement for PXN-2 in development can be bypassed by gain of function in multiple genes encoding other basement
membrane components, or proteins implicated in cell-matrix attachment. We identify multiple alleles of let-805, encoding the trans-
membrane protein myotactin, which suppress phenotypes of pxn-2 null mutants and of other basement membrane mutants such as
F-spondin/spon-1. These let-805 suppressor alleles cause missense alterations in two pairs of FNIII repeats in the extracellular domain; they
act dominantly and have no detectable phenotypes alone, suggesting they cause gain of function. We also identify suppressor missense
mutations affecting basement membrane components type IV collagen (emb-9, let-2) and perlecan (unc-52), as well as a mutation
affecting spectraplakin (vab-10), a component of the epidermal cytoskeleton. These suppressor alleles do not bypass the developmental
requirement for core structural proteins of the basement membrane such as laminin or type IV collagen. In conclusion, putative gain-of-
function alterations in matrix proteins or in cell-matrix receptors can overcome the requirement for certain basement membrane proteins
in embryonic development, revealing previously unknown plasticity in the genetic requirements for the extracellular matrix.
KEYWORDS Peroxidasin; Sulfilimine bond; Myotactin; Spondin; Type IV collagen
BASEMENT membranes (BMs) or basal laminae are spe-cialized extracellular matrices found at the basal surfaces
of nearly all animal tissues (Jayadev and Sherwood 2017).
BMs are critical for numerous developmental processes, from
cell differentiation and specification to organogenesis and
tissue growth (Wiradjaja et al. 2010; Sherwood 2015). BMs
also function in tissue maintenance and provide a barrier for
cell invasion as in metastasis of tumor cells. Complete loss of
function in BM components often results in embryonic lethal-
ity (Smyth et al. 1999), whereas partial loss of function in
humans results in a variety of genetic disorders, including
muscular dystrophy, epidermolysis bullosa (severe skin blis-
tering), ocular defects, and renal disease, as seen in Alport
syndrome (Pozzi et al. 2017).
Assembly of the first BMs in the early embryo involves a series
of partly independent yet coordinated self-assembly processes.
Laminin, typeIVcollagen,heparansulfateproteoglycans(HSPGs)
and nidogen are the most prominent and conserved protein
components of BMs (Yurchenco 2011; Clay and Sherwood
2015; Fidler et al. 2017). Laminins are required for initial BM
assembly, and self-assemble into a cell-associated network inde-
pendently of type IV collagen, as reviewed in Hohenester and
Yurchenco (2013). The laminin network polymerizes in vivo
through binding to cell surface receptors, including integrin
and dystroglycan; laminin can also be anchored to cells through
HSPGsor sulfatedglycolipids (Hohenester andYurchenco2013).
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Type IV collagen heterotrimers assemble into higher-order net-
works via lateral associations and covalent cross-links between
N-terminal domains (Timpl et al. 1981; Yurchenco and Ruben
1987; Chioran et al. 2017). Additionally, a peroxidasin-mediated
sulfilimine bond links the noncollagenous C-terminal (NC1) do-
mains of type IV collagen (Bhave et al. 2012).
In the nematode Caenorhabditis elegans, BMs are present
between most tissue types and contain the core components
such as laminin and type IV collagens. Loss of laminin causes
defects in development beginning in late gastrulation (Huang
et al. 2003). C. elegans encodes two type IV collagen a-chains,
EMB-9 a1 and LET-2 a2, which form a1a1a2 trimers (Sibley
et al. 1994; Gupta et al. 1997; Kubota et al. 2008). Complete
loss of type IV collagen function also results in developmental
arrest later in embryogenesis; weak hypomorphic alleles of
type IV collagen, typically altering a Gly of the Gly-X-Y col-
lagenous motif, result in lower penetrance or temperature-
dependent lethality (Gupta et al. 1997).
Studies of human epidermal BM support the hypothesis
that type IV collagen networks can form layers separate from
laminin networks, and have suggested that these layers are
connected by the HSPG perlecan (Behrens et al. 2012). Per-
lecan has many roles in development and in other processes
(Knox and Whitelock 2006). In Drosophila, perlecan locali-
zation to BM requires type IV collagen, and perlecan is re-
quired to maintain tension of the BM (Pastor-Pareja and Xu
2011). In C. elegans, perlecan does not appear to be a generic
BM component (Mullen et al. 1999) but is enriched at surfaces
of contractile tissues, and is required for muscle-epidermal
attachment (Francis and Waterston 1991; Hresko et al. 1994;
Williams and Waterston 1994).
In addition to these core structural components, BMs have
additional components that have more regulatory or tissue-
specific roles. For example, in C. elegans the specialized BM of
the somatic gonad is required for normal gonad development
and migration, and contains gonad-specific components such
as fibulin, nidogen, and ADAMTS proteases (Kubota et al.
2008, 2012). In contrast, the specialized BM that transduces
force from the body wall muscles to the epidermis contains a
distinct subset of proteins, including the F-spondin SPON-1
(Woo et al. 2008). Here we focus on the epidermal-muscle
BM as it relates to embryonic elongation.
Embryonic epidermal morphogenesis and elongation in C.
elegans involves multiple tissue types (Chisholm and Hardin
2005). Following gastrulation and the enclosure of internal
tissues of the embryo by the epidermis in midembryogenesis,
the embryo elongates into the tubular shape of larval and
adult worms. The epidermis dramatically changes shape dur-
ing elongation, extending almost threefold in the anterior–
posterior axis (Priess and Hirsh 1986). Elongation requires
epidermal cytoskeletal proteins (Ding et al. 2004), as well as
muscle contraction and an intact epidermal-muscle BM
(Williams and Waterston 1994; Chisholm and Hardin 2005).
We previously reported that the C. elegans extracellular
matrix peroxidase PXN-2/peroxidasin is essential for embry-
onic development and elongation (Gotenstein et al. 2010).
Peroxidasin was originally identified as a novel matrix per-
oxidase expressed in Drosophila development (Nelson et al.
1994). Biochemical studies revealed that peroxidasin can
catalyze formation of the sulfilimine bonds required for type
IV collagen network stabilization (Vanacore et al. 2009;
Bhave et al. 2012). In C. elegans, PXN-2/peroxidasin-deficient
animals arrest in late embryonic to early larval development,
predominantly due to severe muscle-epidermal detachment
and aberrant epidermal morphogenesis (Gotenstein et al.
2010). At the muscle-epidermal interface, pxn-2mutants de-
velop an expanded extracellular matrix, containing multiple
electron-dense basement-membrane-like layers. In Drosoph-
ila and zebrafish peroxidasin mutants, mechanical forces
generated during tissue and organ development cause disso-
ciation of BM and result in failed morphological development
(Bhave et al. 2012, 2017; Fidler et al. 2014). Taken together,
genetic analysis of peroxidasins is consistent with their pro-
posed biochemical function in type IV collagen cross-linking.
In C. elegans body wall muscles, dense bodies and M lines
are sites of integrin-based muscle adhesions (Francis and
Waterston 1991), and are enriched for the BM components
UNC-52/perlecan (Rogalski et al. 1993) and EPI-1/laminin
aB (Huang et al. 2003). SPON-1 also localizes to sites of
integrin adhesion; spon-1 mutants arrest in late embryonic
to early larval stages due to severe muscle detachment and
epidermal elongation defects (Woo et al. 2008). SPON-1 does
not appear to be required for laminin assembly; instead,
SPON-1 may be required for proper integrin-mediated adhe-
sion to the BM. The molecular mechanism of SPON-1 or
F-spondin function is not yet understood.
In mammals, a6b4 integrin and collagen XVII/BP180 co-
operatively link the epithelium to BM (Hirako and Owaribe
1998; Zhang and Labouesse 2010). However, the nature of
the epidermal cell-matrix attachment in C. elegans has
remained unclear. C. elegans encodes a single-pass transmem-
brane protein, myotactin/LET-805, which localizes to the
basal side of the epidermis at structures known as fibrous
organelles (Hresko et al. 1999). LET-805 has an extracellular
domain (ECD) consisting of numerous fibronectin type III
(FNIII) repeats, and is distantly related to FNIII-repeat pro-
teins of the Sidekick family. Null mutations in let-805 result
in defective epidermal elongation and fully penetrant em-
bryonic arrest (Hresko et al. 1999). Based on its molecular
architecture, localization, and phenotypes, it has been hy-
pothesized that LET-805 might be required for strong at-
tachment of the epidermis to underlying BM. Moreover,
both LET-805 and Perlecan display dosage sensitivity in cer-
tain genetic backgrounds (Zahreddine et al. 2010). It re-
mains unclear if LET-805 interacts with specific ligands or
whether it transduces signals into the epidermis.
Here, we report the results of large-scale screens for sup-
pression of embryonic lethality in pxn-2 or spon-1 mutant
backgrounds. We discovered multiple suppressor mutations
clustered in a small region of the LET-805 ECD. We also
identified missense suppressor mutations in the core BM
components type IV collagen and perlecan. Genetic analysis
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is consistent with many of these acting as gain-of-function
alleles. These genetic results suggest that compensatory
mechanisms exist within the secreted and membrane-bound
BM components that allow the bypass of otherwise essential
functions.
Materials and Methods
Genetics and strain construction
C. elegans strains were maintained on NGM agar plates at
20–23 following standard procedures. Bristol N2 was used
as wild type for all crosses and scoring. We used the follow-
ing previously reported mutations and transgenes: pxn-2
(tm3464), pxn-2(ju358, ju432, ju436), pxn-1(ok785), spon-
1(ju430ts, e2623), pxn-2+(juEx1044), Ppxn-2-PXN-2(juEx2140)
(Gotenstein et al. 2010); vab-10(e698), vab-19(e1036cs) (Ding
et al. 2003), emb-9::Dendra (qyIs161) (Ihara et al. 2011); emb-
9(b189ts), emb-9(g23cg46) (Gupta et al. 1997), let-2(b246)
(Sibley et al. 1994) let-2(k193), let-2(k196) (Kubota et al.
2008). Strains used are listed in Supplemental Material,
Table S1 in File S1.
vab-10(ju958) arose as a spontaneous suppressor in a pxn-
2(ju358) strain. let-805 suppressors ju1122 and ju1123were
isolated in a semiclonal screen of20,000 EMSmutagenized
haploid genomes for suppression of the null pxn-2(tm3464)
mutant to viability in the absence of the pxn-2(+) juEx1044
GFP+ rescuing transgenic array. Suppressors ju1165–ju1198
were isolated from a nonclonal screen for EMS-induced sup-
pressors of lethality of the temperature sensitive allele
spon-1(ju430ts). After mutagenesis, F2 and F3 animals were
shifted from the permissive (15) to the nonpermissive (25)
temperature. Surviving animals were propagated to gener-
ate suppressed mutant lines. Approximately 40,000 haploid
genomes were screened.
CRISPR mutagenesis and GFP knock-in
Single-guide RNA Cas9 vectors were cloned using the vector
Addgene #47549 and the Quikchange mutagenesis protocol
as described (Dickinson et al. 2013), except that Phusion
hi-fidelity enzyme and buffer were substituted for Q5; see
Table S3 in File S1 for targeting sequences. Point mutations
were made using the dpy-10(cn64) co-CRISPR strategy as
described (Arribere et al. 2014). A 121 bp oligonucleotide
(Ultramer DNA; Integrated DNA Technologies) containing
the desired change with 60 bp homology arms was used as
repair template for the induced SNPs. Deletions ju1299 and
ju1300 were generated in the course of attempting to recre-
ate the vab-10(ju958) SNP. Recreation of the ju1123 T/C
(C1424R) SNP to generate ju1386 used the dpy-10(cn64)
co-CRISPR strategy with let-805(ju1123) single-guide RNA
and oligo repair template.
GFP was inserted at the C-terminus of let-805 in N2 (wild
type) and suppressor alleles CZ19652 ju1123, CZ26231
ju1165, and CZ25774 ju1184 using the Self-Excising Drug Se-
lection Cassette as described (Dickinson et al. 2015). Homology
arms were cloned into the pDD282 GFP-SEC-3xFlag vector to
insert GFP directly before the stop codon. An AvrII/SpeI digest
was used to include a flexible linker (RGASGASGAS) before the
GFP sequence.
LET-805::GFP image analysis
For each strain, adult worms grown at 20 for 24 hr after L4
stage we immobilized on 10% agarose pads. We took 5 mm,
six-slice z-stack images of the midbody region centered on
the vulval/uterine lumen on a Zeiss710 confocal microscope
and exported as a maximum intensity projection. LET-805::
GFP aggregation at the uterine seam was quantified using
ImageJ particle analysis. A total of 12 images of each geno-
type were analyzed at 4 mm from the GFP localization at the
uterine lumen. A region of interest of 303 120 pixels (133
52mm)was used on each side of the uterine seam. Aminimum
threshold of 35 and a maximum of 255 were used to detect
particles. Combined total area of all identified particles in each
region of interest is reported.
Transgenes
The following extrachromosomal transgenes were generated
by injections of fosmid or plasmid DNA into N2 worms with
Pttx-3-RFP as a co-injectionmarker: juEx3911–juEx3915 con-
tain let-2 fosmid WRM0640bA06 (10 ng/ml), juEx4356–
juEx4360 contain emb-9 fosmid WRM0610dH07 (10 ng/ml),
and juEx4361–juEx4365 were made by injecting a mix of the
above emb-9 and let-2 fosmids (10 ng/ml each).
Whole genome sequencing and genetic mapping
Linkagemapping of the pxn-2 suppressor ju958was performed
by crossing pxn-2(tm3464); ju958 suppressed worms to the
Hawaiian strain CB4856. ju958was mapped to chromosome I
between N2/CB4856 SNPs located at11,550 kb (+9.17 cM)
and 12,950 kb (+15.72 cM). vab-10 is at 11,750 kb (+9.62
cM).Worm genomic DNAwas prepared for sequencing follow-
ing the Gentra Puregene Tissue Kit DNA purification protocol.
Whole genome sequencing (WGS) was performed by BGI, and
analyzed as described (McCulloch et al. 2017). Strains were
sequenced in batches, using the most outcrossed version of
each suppressor available at the time. After the identification
of the let-805 “hotspot” regions, all suppressor strains were
sequenced specifically in these regions and five new let-805
alleles identified this way (Table 1). Strains in which no mu-
tation was detected in the let-805 hotspots were prepared for
WGS.
Phenotypic analysis of suppression
We quantitated the penetrance of lethal and epidermal mor-
phology defects essentially as described (George et al. 1998).
For each genotype, the entire self-progeny brood of P0 animals
was quantified (n = 5). P values were determined for total
lethality using Student’s t-test, assuming two-tailed unequal
variance. To test heterozygous suppression of pxn-2(tm3464),
we crossed homozygous suppressed males to transgenically
rescued null mutants, pxn-2(tm3464); juEx1044. Broods of
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five nontransgenic F1 progeny were quantified at 20 unless
specified. In the case of let-2(ju1166/+), we were unable to
isolate viable F1 heterozygotes, so broods of nontransgenic
F2s from let-2(ju1166/+); pxn-2(tm3464);juEx1044 parent
worms were quantified and genotyped to confirm the hetero-
zygosity of parent worms. For complementation testing, sin-
gle hermaphrodites were mated to homozygous males; four
single hermaphrodite crosses were quantified. Quantitative
data are in Table S1 in File S1. Suppression of pharynx BM
defects was assessed by DIC analysis of day 1 adult worms
grown at 20. Worms were analyzed for bulging in either
bulb of the pharynx.
RNA interference
We performed RNA interference (RNAi) by feeding. Worms
were grown at 20 throughout. L4 worms transferred to 5 mM
IPTG, 50mg/ml carbenicillin plates seededwithRNAi bacteria.
After 24 hr, three adult worms per genotype and per clone
were transferred to individual plates. After 24 hr, parent worms
were removed from plates. Progeny were counted and pheno-
types assessed after an additional 24 hr. We used clones from
the Ahringer library: clone III-1J01 for let-805 and clone III-
5A13 for emb-9 (Kamath et al. 2003). A GFP RNAi clone (gift
from E. Troemel, University of California, San Diego)was used
to target LET-805::GFP. For the lethal pxn-2(tm3464), parent
worms expressing a transgenic extrachromosomal array
(juEx1044) of cosmid K09C8 (pxn-2) + Psur-5-GFP were
plated. Only nontransgenic progeny were assessed.
Protein sequence alignments and structural modeling
We performed alignments of LET-805 with other FNIII re-
peat-containing proteins using BLAST. The numbering of
FNIII repeats in Figure S2 in File S1 is based on reanalysis
with additional protein domain prediction algorithms; sequence
alignments use ClustalX. Protein domain graphics were gener-
ated using IBS software (Liu et al. 2015), based on domains
identified in the conserved domain database of the National
Center for Biotechnology Information (Marchler-Bauer et al.
2015). Predicted structures of subsets of the LET-805 FNIII
repeats were generated using SWISS-MODEL (Arnold et al.
2006). Models in Figure S3 in File S1 are based on the human
IL-6 receptor FNIII repeats.
Data availability
The authors state that all data necessary for confirming the
conclusions presented in the article are represented fully
within the article.
Results
Identification of a novel mutation in spectraplakin
vab-10 that suppresses developmental defects of
peroxidasin pxn-2 mutants
We previously reported that C. elegans pxn-2 mutants have
defective BMs, leading to aberrant tissue morphogenesis and
lethality (Gotenstein et al. 2010). pxn-2(ju358) is a partial
Table 1 Summary of suppressors
Gene Allele Chromosome Residue change
Codon change
(wild type/mutant)
Mutation
identificationa/strain
% Lethality
in ju430b
% Lethality
in tm3464
— — — — — — 99.8 100
vab-10 ju958 I D941N Gat/Aat WGS/mapping CZ13802 79.3 55.1
vab-10 ju1299 I DD929-A937 27 bp D CRISPR ND (31.2 in ju358c)
vab-10 ju1300 I DR931-D941 33 bp D CRISPR ND (35.1 in ju358c)
unc-52 ju1168 II C402Y tGc/tAc WGS CZ21257 6.0 2.4
unc-52 ju1172 II R1442C Cgt/Tgt WGS CZ23560 51.0 11.4
unc-52 ju1174 II R175C Cgc/Tgc WGS CZ21494 36.5 19.0
unc-52 ju1188 II E1480K Gag/Aag WGS CZ22297 ND ND
emb-9 ju1197 III P141L cCa/cTa WGS CZ22017 37.2 33.8
let-2 ju1166 X E480K Gaa/Aaa WGS CZ20580 11.0 29.2
let-2 ju1180 X P588L cCa/cTa WGS CZ21496 31.2 23.1
let-805 ju1122 III E1547K Gaa/Aaa WGS CZ18264 38.5 20.6
let-805 ju1123 III C1424R + R1584K Tgc/Cgc + aGa/aAa WGS CZ18265 25.1 6.9
let-805 ju1386 III C1424R Tgc/Cgc CRISPR 24.3 1.7
let-805 ju1165 III S1594F tCc/tTc WGS CZ20579 8.9 4.8
let-805 ju1167 III G1541E gGa/gAa WGS CZ20581 33.7 ND
let-805 ju1170 III R1076C Cgt/Tgt WGS CZ20988 36.8 36.2
let-805 ju1173 III R970C Cgt/Tgt WGS CZ20990 9.3 61.1
let-805 ju1175 III R1443C Cgt/Tgt Resequencing 44.8 ND
let-805 ju1177 III G1541R Gga/Aga Resequencing 32.1 ND
let-805 ju1184 III G1578E gGa/gAa Resequencing 4.5 32.6
let-805 ju1187 III P1422R cCa/cGa WGS CZ22296 29.0 2.5
let-805 ju1190 III V1052I Gtc/Atc Resequencing 47.1 ND
let-805 ju1198 III A1552V gCt/gTt Resequencing 37.4 ND
a WGS, Whole genome sequencing. Resequencing, Sanger sequencing of let-805 hotspots.
b at 25.
c ju358 is a viable, strong loss-of-function allele of pxn-2. The single mutant displays 58.5% lethality.
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loss of function allele that causes60% embryonic and larval
lethality and severe morphology defects (Gotenstein et al.
2010); pxn-2(ju358) homozygotes can be propagated as
slow-growing strains. We identified a fast-growing variant
strain in the course of routine propagation and confirmed
that it retained the original pxn-2(ju358) mutation. This sup-
pressed strain, pxn-2(ju358) sup(ju958), displays,5% lethality
and almost no detectablemorphological defects. Following out-
crossing and genetic mapping, we showed that the suppressor
ju958 mapped to a 1.4 Mb region on chromosome I. WGS
analysis revealed a single missense alteration in this region,
affecting vab-10. vab-10 encodes two sets of spectraplakin
isoforms, VAB-10A and VAB-10B, each essential for embry-
onic morphogenesis and epidermal integrity (Bosher et al.
2003). The ju958 missense mutation alters residue D941N
in a linker between N-terminal spectrin repeats common to
VAB-10A and VAB-10B (Figure 1A). In contrast to vab-10 loss-
of-function alleles, ju958 single mutants were fully viable and
displayed normal morphology.
We found that ju958 was able to suppress the pxn-
2(tm3464) null allele [hereafter, pxn-2(0)] to viability
(Figure 1B). We previously reported suppression of pxn-2
by the superficially wild-type pxn-1(ok785) null mutation
(Gotenstein et al. 2010). Triple mutant vab-10(ju958); pxn-
1(ok785); pxn-2(0) animals showed additive suppression of
pxn-2 (Table S1 in File S1), suggesting that the mechanisms
of suppression by pxn-1 and by vab-10(ju958) are distinct. To
test specificity of the suppression for BM defects we tested
an additional BM mutant, spon-1(ju430ts), and found that
ju958 partially rescues the conditional lethality of spon-1
(Figure 1B). Thus, suppression by vab-10(ju958) is not gene
specific.
The vab-10 locus extends over 45 kb, precluding standard
transgenic rescue or reconstruction experiments. To confirm
whether the vab-10(D941N) missense alteration was causa-
tive for suppression, we performed CRISPR-mediated muta-
genesis of wild-type animals at the vab-10(D941) locus and
isolated two small, in-frame deletions adjacent to or encom-
passing the residue affected in ju958 (Figure 1A). These de-
letions, ju1299 and ju1300, partially suppressed phenotypes
of pxn-2(ju358) (Figure 1C), although they did not suppress
the pxn-2 null allele to viability. As these deletions also
showed suppression of pxn-2(ju358), we conclude that vab-10
mutations in this region are causative for suppression of pxn-2
loss of function.
Suppressor screening of pxn-2 and spon-1 identified
novel mutations in components of the BM and cell-
matrix attachments
Encouraged by the finding that pxn-2 null mutant phenotypes
can be suppressed to viability, we screened directly for EMS-
induced suppressors of pxn-2(0) phenotypes (see Materials
and Methods) and recovered two suppressors that were iden-
tified as alleles of let-805. As described below, these let-805
alleles also suppressed lethal phenotypes of spon-1/F-spondin.
We therefore took advantage of the temperature sensitive
lethality of a partial loss-of-function allele, spon-1(ju430ts),
to perform a larger-scale selection for suppressors (see Mate-
rials and Methods). We recovered 34 additional suppressors of
spon-1(ju430ts). By mapping andWGS, we identified 10 addi-
tional alleles of let-805/myotactin, three affecting emb-9 or
let-2 (type IV collagen) and four affecting unc-52/perlecan
(Table 1). Seventeen additional suppressors will be described
elsewhere.
Peroxidasin pxn-2 displays specific genetic interactions
with type IV collagen mutations and transgenes
C. elegans type IV collagen is composed of heterotrimers of
two a1-like (EMB-9) and one a2-like (LET-2) chains (Kramer
2005). Of the three suppressor mutations we identified as
affecting type IV collagen chains, two cause missense alter-
ations in LET-2 and one affects EMB-9. In contrast to pre-
viously reported loss- or gain-of-function alleles of C. elegans
type IV collagen (Sibley et al. 1994; Kubota et al. 2008),
these suppressor alleles do not cause detectable phenotypes
as single mutants, and suppress the lethality of pxn-2 null
and of spon-1 loss of function (Figure 2A). All three affect
non-Gly residues within the Gly-X-Y repeats of the collage-
nous a-helical domain; two cause Pro-to-Leu missense
changes (Figure 2B). In humans, mutations in type IV colla-
gen are known to cause dominantly inherited cerebrovascular
disease; a Pro-to-Leu missense change in COL4A1 has been
identified in a patient with sporadic cerebral hemorrhage
(Weng et al. 2012). This study observed increased intracellu-
lar aggregation of this type IV collagen variant, similar to the
effects of mutations affecting Gly residues in the Gly-X-Y re-
peats. In C. elegans, complete loss of function in let-2 or emb-9
causes fully penetrant embryonic lethality, so suppressor al-
leles of these genes might be either very weak loss of function
or gain of function. emb-9(ju1197) fully complemented the
lethality of emb-9 null mutants (Table S1 in File S1), consis-
tent with a gain of function. Moreover, emb-9 RNAi abro-
gated the suppression of pxn-2(0) by emb-9(ju1197) at
RNAi dosages that do not cause defects in a wild-type back-
ground or enhancement of pxn-2(0) (Figure S1A in File S1).
let-2(ju1166)/+ heterozygotes displayed weak suppression
(Figure S1B in File S1). Overall, our analysis is most con-
sistent with a gain-of-function model for these suppressor
alleles of type IV collagen.
Given the findings that insect andmammalian peroxidasins
can promote formation of sulfilimine bonds between type IV
collagen NC1 domains in vitro (Bhave et al. 2012), we sought
genetic evidence that C. elegans pxn-2 functions in type IV
collagen cross-linking in vivo. If PXN-2 functions to promote
type IV collagen cross-linking, loss of function in pxn-2 and
type IV collagen should synergize genetically. The temperature-
sensitive allele emb-9(b189) causes 100% lethality at the re-
strictive temperature 25, although it is 98% viable at 20.
When combinedwith emb-9(b189), the relatively weak allele
pxn-2(ju436) caused a 30-fold increase in lethality at 20
(Figure 2C). We were unable to test interactions at 25, as
surviving double mutants were sterile. The strongest viable
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allele pxn-2(ju358) was 100% lethal in combination with
b189: double mutants arrested at the threefold stage of em-
bryogenesis (Figure 2D), similar to pxn-2 (Gotenstein et al.
2010) and emb-9 (Gupta et al. 1997) null mutants. Type IV
collagen mutant phenotypes were not modified by loss of func-
tion in the other C. elegans peroxidasin gene pxn-1 (Figure 2C).
We observed a similar synergism between a weak allele of
a2 type IV collagen, let-2(b246), with the hypomorphic allele
pxn-2(ju436). Double mutant strains were nearly 50% lethal,
whereas single mutants displayed minimal defects. In addi-
tion, we tested interaction of a reported type IV collagen gain-
of-function allele, let-2(k193), which alters an amino acid
residue in the NC1 domain, with an intermediate loss-of-
function allele pxn-2(ju432) to potentially detect either sup-
pression or synergy. let-2(k193) affects gonad development
but does not cause embryonic lethality (Kubota et al. 2008).
This type IV collagen allele strongly enhanced pxn-2(ju432)
lethality (Table S1 in File S1), similar to the type IV collagen
loss-of-function alleles. In contrast, type IV collagen loss-of-
function mutations did not display synergistic lethality with a
weak allele of spon-1 e2623 (Figure 2C). Collectively, these
genetic interactions support the specific synergy of type IV
collagen with PXN-2.
We also tested whether overexpression of type IV collagen
might bypass the need for pxn-2. Among multiple transgenes
tested, we found that a transgenic array of emb-9(+) fosmid
significantly reduced the lethality and morphological defects
of a partial loss-of-function mutant pxn-2(ju358) (Figure 2E),
although this array was not able to suppress pxn-2 null mutant
lethal phenotypes. Transgenes containing the let-2(+) fosmid
alone or a combination of let-2 and emb-9 fosmids were less
effective at suppressing pxn-2(ju358) phenotypes (Figure 2E),
likely due to the 2 EMB-9:1 LET-2 composition of type IV
collagen. In contrast, transgenic arrays expressing type IV col-
lagen were unable to suppress spon-1(ju430ts) phenotypes
(Figure 2E), suggesting SPON-1 does not directly affect type
IV collagen function. Together with our double mutant analy-
ses, these genetic interactions are consistent with PXN-2 play-
ing a specific role in type IV collagen function in vivo.
Gain-of-function mutations in a critical region of the
LET-805 ECD suppress pxn-2 and spon-1 null
mutant phenotypes
We identified 12 suppressor mutations as causing missense
alterations in LET-805/myotactin (Figure 3A). The let-805
gene encodes a predicted single-pass transmembrane protein
containing fibronectin type III (FNIII) repeats in its ECD
(Hresko et al. 1999). Through sequence alignment and do-
main analysis (seeMaterials and Methods), we identified four
additional FNIII repeats as well as the 32 previously anno-
tated (see Figure S2 in File S1). Strikingly, all 12 of the iden-
tified let-805 suppressor alleles affect two pairs of adjacent
FNIII repeats (repeats 9+10 and 14+15, as numbered in
Figure 3A and Figure S2A in File S1) in the middle of the
ECD. Although the three alleles located in FNIII repeats 9+10
were generally weaker suppressors than mutations affecting
repeats 14+15, overall these let-805 mutations displayed
strong suppression of lethality of null or loss-of-function al-
leles of both spon-1 and pxn-2 (Figure 3, B and C and Figure
5). Moreover, ju1123 displayed semidominant suppression of
pxn-2(0) (Figure S1C in File S1). As loss of function in let-805
causes fully penetrant recessive embryonic lethality (Hresko
et al. 1999), we hypothesize ju1123 and other suppressor
alleles of let-805 cause a gain of function. Consistent with
this interpretation, let-805 RNAi by feeding, which does not
cause lethality in awild-type background, abrogated suppres-
sion in a let-805(ju1123); pxn-2(0) background (Figure S1, D
and E in File S1).
To confirm that the let-805 missense changes were caus-
ative for genetic suppression, we used CRISPR to recreate the
base transition causing the C1424R alteration, one of two
missense changes in the original let-805(ju1123) suppressor
Figure 1 Suppression of BM mu-
tants by a spontaneous mutation in
vab-10. (A) Structure of VAB-10 A
and B protein domains with ju958
D941N and deletions noted. (B)
vab-10(ju958) suppresses pxn-2 null
to viability; ju958 partially sup-
presses spon-1(ju430ts) lethality
at nonpermissive temperature.
(C) Small in-frame deletions gen-
erated by CRISPR near the vab-
10(ju958) missense residue partly
phenocopy the suppression of
pxn-2(ju358) by ju958. Results of
Student’s t-test for percent total
lethality (sum of embryonic and
larval lethality). * P , 0.05,
** P , 0.01, *** P , 0.001.
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strain. The resulting mutant, denoted ju1386, suppressed
both spon-1 and pxn-2 phenotypes to levels equivalent to
the original let-805(ju1123) suppressor (Figure 3, B and C).
These observations confirm that missense alterations in the
LET-805 ECD can suppress the requirement for pxn-2 or spon-1
in development.
PXN-2 and SPON-1 likely have distinct molecular roles in
the BM; consistent with this, pxn-2 but not spon-1 was
suppressed by transgenic overexpression of type IV collagen
(Figure 1F). Nevertheless it is striking that almost all the
let-805 alleles isolated as suppressors of spon-1(ju430ts)
were subsequently found to suppress pxn-2 null phenotypes,
suggesting a correlation between suppression of pxn-2 and
spon-1. We compared the relative level of suppression of
spon-1 and pxn-2, using eight let-805 alleles. Overall there is
a correlation between suppression of spon-1with suppression
of pxn-2 (Figure 3D), with the exception of let-805(ju1184),
which strongly suppresses spon-1 phenotypes but weakly
suppresses pxn-2. If ju1184 is excluded, suppression of the
two loci is strongly positively correlated, suggestive of a
common mechanism of suppression.
To understand how thesemissense alterationsmight affect
LET-805 structure, we modeled the four FNIII repeats af-
fected by the suppressor mutations (see Materials and Meth-
ods) (Figure S3 in File S1). The predicted structures are
consistent with these repeats forming a binding interface that
Figure 2 Genetic interactions of type IV collagen mutants with peroxidasin pxn-2. (A) Novel type IV collagen alleles suppress both pxn-2(tm3464) null
and spon-1(ju430ts) to viability. (B) Structure of EMB-9 and LET-2 proteins with location of alleles annotated. Novel type IV collagen alleles: ju1166
causes E480K in LET-2, ju1180 causes P588L in LET-2, and ju1197 causes P141L in EMB-9. (C) Loss of function in pxn-2 synergistically enhances the
lethality of weak type IV collagen let-2 or emb-9mutants. A null mutation in pxn-1 does not show synergistic enhancement with type IV collagen alleles.
Additionally spon-1 loss of function is unaltered by type IV collagen loss of function. (D) Time series of emb-9(b189); pxn-2(ju358) embryo from comma
to arrest. (E) Transgenes containing type IV collagen DNA can partially rescue lethality of pxn-2(lf), but not spon-1(lf). Results of Student’s t-test are
indicated for percent total lethality (sum of embryonic and larval lethality). * P , 0.05, ** P , 0.01, *** P , 0.001.
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is affected by the suppressor missense mutations. The mis-
sense alterations could directly alter the affinity of LET-805
for an as-yet unidentified ligand. Alternatively, mutations
in this region of the ECD could result in a conformational
change that alters LET-805 signaling independent of ligands.
Suppression of pxn-2 or spon-1 lethal phenotypes could be
for a number of reasons. We therefore examined whether
specific pxn-2 phenotypes attributed to BM defects were
altered by the let-805 suppressors. Four-dimensional time-
lapse analysis of let-805(ju1123) pxn-2(0) animals confirmed
that suppressed animals showed restored epidermal mor-
phology and body wall muscle attachment (data not shown).
In adults, we observed type IV collagen and found distortions
in the structure of BM tracks in pxn-2(ju358) compared to
wild type (Figure 4, A and B). These distortions were elimi-
nated in suppressed let-805(ju1123) pxn-2(0) animals (Fig-
ure 4C). Furthermore, the progressive distortions in pharyngeal
morphology of pxn-2(ju358) hypomorphs were fully sup-
pressed by let-805(ju1123) (Figure 4, D–F). Taken together,
these analyses are consistent with let-805 alleles suppress-
ing multiple pxn-2 mutant phenotypes that result from ab-
errant BM function.
let-805 alleles suppress phenotypes due to partial loss
of function in the BM, but not due to loss of function in
the epidermal cytoskeleton
Given the observed synergism of loss-of-function mutations in
pxn-2 with type IV collagen, we next tested whether let-805
suppressor alleles could also suppress type IV collagen mutant
phenotypes. We found that let-805(ju1123) partially sup-
pressed the lethality of emb-9(b189ts) at the intermediate tem-
perature of 22.5 (Figure 5), but did not suppress the sterility
of b189 mutants shifted to 25. let-805(ju1123) also sup-
pressed the lethality of let-2(b246ts) at the intermediate tem-
perature of 22.5, but did not significantly suppress b246 at the
restrictive temperature of 25 (Figure 5). let-805(ju1123) did
not suppress either emb-9(tk75gf) or let-2(k193gf) (Figure 5).
To address whether let-805 suppressor alleles bypass the
requirement for type IV collagen, we attempted to test a null
allele emb-9(g23cg46) but were unable to generate a viable
let-805(ju1123); emb-9(g23cg46) strain. We further found
that let-805(ju1123) was able to suppress the phenotypes of
a partial loss-of-function mutation in the laminin aB chain
gene epi-1(gm121) (Forrester and Garriga 1997) (Figure 5).
Taken together, these data indicate that the let-805 gain-of-
function mutations can suppress defects in BM integrity due
to complete loss of function in nonstructural genes (pxn-2,
spon-1) or partial loss of function in structural genes (type IV
collagens, laminins), but are unable to bypass the require-
ment for structural BM components.
Given the suppression of BM mutant defects by vab-
10(ju958), we also tested whether let-805(ju1123) sup-
pressed mutant defects of epidermal cytoskeletal proteins
including vab-10 and other components of trans-epidermal
attachments, where LET-805 is known to localize. Partial
loss of function in genes encoding cytoskeleton components
Figure 3 Missense mutations in
the let-805 ECD suppress pheno-
types due to loss of function in mul-
tiple components of the BM. (A)
Domain structure of LET-805, indi-
cating the two pairs of FNIII repeats
affected in suppressor alleles. See
also Figure S2 in File S1. (B) Level
of suppression of spon-1(ju430)
lethality and Vab phenotypes by
let-805 alleles at 25. (C) Level of
suppression of pxn-2(tm3464) null
mutant lethality and Vab pheno-
types by let-805 alleles at 20. (D)
Correlation of strength of suppres-
sion of spon-1 vs. pxn-2 by let-805
suppressors. Solid line shows corre-
lation trend line excluding ju1184
(slope = 0.86 6 0.40); dotted line
shows correlation trend line includ-
ing ju1184 (slope = 0.19 6 0.33).
Results of Student’s t-test for per-
cent total lethality (sum of embry-
onic and larval lethality). ** P ,
0.01, *** P , 0.001.
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(including vab-10/spectraplakin, intermediate filament ifb-1,
and vab-19/Kank) were not suppressed by let-805 suppressor
alleles (Figure S4 in File S1), suggesting suppression is spe-
cific to defects in BM components.
The LET-805 gain-of-function mutations do not overtly
affect protein expression level or localization, but cause
aggregation of LET-805::GFP
To assess whether let-805missense mutations affect LET-805
localization or levels, we used CRISPR to insert a C-terminal
GFP tag in the wild-type, ju1123, ju1165, and ju1184mutant
let-805 loci (see Materials and Methods). All these GFP
knock-in animals were fully viable. Wild-type LET-805::GFP
localized to epidermal hemidesmosomes, from midembryo-
genesis onwards (Figure 6), as expected from prior immuno-
cytochemical studies (Francis and Waterston 1991). We also
observed localization at the pharynx and uterine seam,
consistent with previous results (Francis and Waterston
1991), and along touch neuron processes (Figure 6). These
are all regions of the epidermis that require strong adhesive
coupling to internal cells. The expression and localization of
LET-805(ju1123)::GFP in embryos was overall similar to that
of wild-type LET-805::GFP. However, in adults the aggrega-
tion of LET-805(ju1123)::GFP at the uterine-epidermal con-
tact was significantly increased compared to the wild type
(Figure 6, D–F). Increased aggregation compared to wild
type was seen in all three knock-in alleles (Figure 6F). We
conclude that the suppressor missense changes do not dra-
matically affect LET-805 levels or localization, but might en-
hance its tendency to cluster, consistent withmodels whereby
LET-805 undergoes dimerization or multimerization.
Wild-type LET-805::GFPwas severelymislocalized in spon-1
or pxn-2 mutants (Figure S5 in File S1), consistent with the
epidermal-muscle detachment observed in these animals (Woo
et al. 2008; Gotenstein et al. 2010). The suppressor LET-
805(ju1123)::GFP strongly restored localization and proper
hemidesmosomemorphology in pxn-2 or spon-1mutants, from
late embryos through to adults (Figure S5 in File S1), indicating
that the GFP tag does not affect the gain of LET-805 function.
Mutations in UNC-52 perlecan can suppress lethality of
pxn-2 and spon-1 mutants
We identified four additional suppressors of spon-1 as affect-
ing the unc-52 gene, encoding the BM component perlecan
(Figure 7A). Unlike let-805 suppressor alleles, the unc-52
suppressor alleles affect distinct functional domains across
the protein; all four strongly suppress both pxn-2 and spon-1
mutant lethality (Figure 7B). The strongest suppressor unc-
52(ju1168) affects a laminin-type EGF-like domain. The resi-
due affected in ju1168 is conserved with human HSPG2. In
contrast, unc-52(ju1174) affects a nonconserved residue be-
tween a conserved Cys and the conserved DXSDE motif in
the LDL receptor-like domain of perlecan. Loss of function in
specific isoforms of UNC-52 results in adult locomotor defects
Figure 4 Suppression of BM defects by let-805(ju1123). Functional EMB-9::Dendra (qyIs161, fluorescence is shown as inverted, grayscale, projections
of z-stacks of superficial sections) localizes to BM overlying body wall muscles and pharynx, as well as accumulating in intracellular aggregates, in wild
type (A) and in let-805(ju1123) (data not shown). In pxn-2(ju358), the normal linear localization of EMB-9::Dendra is interrupted (B, arrowhead). (C)
EMB-9::Dendra localization is essentially normal in suppressed let-805(ju1123); pxn-2(tm3464) animals. (D–F) Distortions in pharyngeal morphology of
pxn-2 young adults (arrowhead, D) are completely suppressed by let-805(ju1123) (image, E and quantitation, F). Scale bars, 10 microns.
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(Unc) due to progressive loss of muscle structure (Rogalski
et al. 1995). The final two suppressors affect an Ig domain of
Perlecan domain IV. Many of the previously identified Unc
mutants localize to this region (Mullen et al. 1999). However,
unlike previously identified unc-52 variants, the suppressor
alleles do not display Unc or Let phenotypes, suggesting unc-
52 suppressor allelesmay cause gain of function orweak loss of
function. Consistent with a gain-of-function interpretation,
unc-52(ju1168)/+ heterozygotes displayed semidominant
suppression of pxn-2(0) (Figure S1F in File S1). Conversely,
the hypomorphic allele unc-52(e444) displayed additive
phenotypes when combined with the weak allele pxn-2(ju436)
(data not shown), suggesting loss of unc-52 function does
not modify pxn-2 phenotypes.
The unc-52 suppressor mutants also partially suppress loss
of function in type IV collagen emb-9(b189) (Figure 7B), com-
parable to the let-805 suppression of type IV collagen mu-
tants (Figure 5). Previous studies have suggested myotactin/
LET-805 and perlecan/UNC-52 function are closely related
(Zahreddine et al. 2010). We therefore tested whether let-
805 suppressor alleles could suppress unc-52 loss of function.
The Unc phenotypes of the partial loss-of-function allele unc-
52(e444) were unaltered by the let-805(ju1123) suppressor
(Table S1 in File S1). We also tested the putative null allele,
unc-52(st549) (Rogalski et al. 1995), which causes fully pen-
etrant embryonic lethality, and found that this lethality was
not suppressed by let-805(ju1123). This finding suggests that
the requirement for certain BM components, such as perlecan,
type IV collagen, and laminin, is not bypassed by the kinds of
LET-805 altered function mutations described here.
Discussion
Starting from the chance observation of extragenic suppres-
sion of C. elegans peroxidasin/pxn-2 phenotypes, we have
found that a variety of genes can be mutated to suppress
otherwise lethal phenotypes of matrix mutants. Our genetic
analysis of pxn-2 supports the model that peroxidasins are
critical for type IV collagen cross-linking. Nevertheless, the
essential role of pxn-2 can be bypassed by putative gain-of-
function alterations in other essential BM components or in
the putative matrix receptor LET-805. These suppressor alleles
also suppress phenotypes due to loss of function in SPON-1. As
PXN-2 and SPON-1 likely play different roles in the BM, such
suppression may act at the overall level of matrix function
rather than compensation for loss of a specific pathway or
interaction. These genetic suppression interactions reveal a
previously unknown capacity for compensatory interactions
between these individually essential genes.
Genetic interactions are consistent with peroxidasin and
type IV collagen functioning in a common process
Our observations of synergism between loss-of-function mu-
tations in the type IV collagen a1 emb-9 and pxn-2, as well as
rescue of pxn-2 phenotypes by transgenic overexpression of
type IV collagen, is consistent with PXN-2 promoting type IV
collagen function in C. elegans. From other biochemical stud-
ies, peroxidasins are believed to catalyze sulfilimine cross-links
between type IV collagen NC1 domains. In a pxn-2 mutant
background, formation of these sulfilimine bonds is presum-
ably reduced, although our efforts to directly assess type IV
collagen cross-linking have been unsuccessful, as the embry-
onic lethality of pxn-2 mutants precludes biochemical analy-
sis. We infer that the combination of partial reduction in type IV
collagen cross-linking and partial loss of function in a type IV
collagen chain results in severely compromised structural in-
tegrity of the BM and subsequent embryonic lethality.
The mechanism by which putative gain-of-function muta-
tions in type IV collagen results in suppression of pxn-2 remains
uncertain. The strong suppression of spon-1 argues against a
direct bypass of the pxn-2–mediated sulfilimine bond. Given the
location of the type IV collagen suppressor alleles in the collag-
enous domain, we speculate that the mutations may enhance
lateral associations of parallel collagen chains (Yurchenco and
Ruben 1987; Knupp and Squire 2005), potentially relaxing the
requirement for peroxidasin-mediated cross-linking of the NC1
domains. Hydroxylated proline and/or lysine have been shown
to increase the thermostability of collagen (Berg and Prockop
1973). By analogy, a general increase in type IV collagen stabil-
ity could overcome the need for sulfilimine cross-linking and
thus allow genetic suppression of pxn-2 phenotypes.
Role of myotactin/LET-805 in BM interactions
LET-805/myotactin is a giant transmembrane protein whose
ECD is composed solely of FNIII repeats. Although myotactin
Figure 5 let-805(ju1123) sup-
presses lethality and morphologi-
cal defects due to partial loss of
function in core structural BM
components, including the type
IV collagen chains emb-9 and let-2
and the laminin subunit epi-1. let-
805(ju1123) did not suppress de-
fects of emb-9(tk75) or let-2(b246)
at the restrictive temperature. Re-
sults of Student’s t-test are indi-
cated for percent total lethality
(sum of embryonic and larval lethal-
ity). ** P , 0.01, *** P , 0.001.
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is not conserved outside of nematodes, it has been proposed
toplay ananalogous role to thehemidesmosome transmembrane
protein BPAG2 (formerly BP180) (Hresko et al. 1999), which
interacts directly with a6b4 integrin and with the intracellu-
lar plakin domains of plectin (Koster et al. 2003). As BPAG2
and myotactin show no sequence similarity, it is unclear
whether they share any commonmechanisms. It is intriguing
that missense alterations in let-805 and the spectraplakin
VAB-10 can result in similar genetic suppression of BM
defects
The suppressors identified as LET-805 missense changes
alter a variety of amino acid residues of its FNIII repeats, in
general resulting in either removal of or addition of a charged
residue. All residues affected are conserved in the equivalent
repeats of myotactin orthologs in other nematodes (Figure
S2C in File S1), but are not conserved in the other FNIII
repeats of C. elegans myotactin or of other Sidekick family
members (Figure S2, A and B in File S1), suggesting these
four FNIII repeats may have distinctive roles in myotactin
function. The most distinctive features of these repeats are
sequences of nonconserved residues between FNIII repeats
8 and 9, and in the middle of FNIII repeat 15 (underlined in
red, Figure S2A in File S1). Linker regions between FNIII
repeats are important for function in other molecules such
as fibronectin itself (Vakonakis et al. 2007). As FNIII repeats
are often in large clusters, there are scant examples of single
missense alterations having phenotypic consequences. A mis-
sense alteration in a FNIII repeat in the PTPRQ transmem-
brane phosphatase has been linked to deafness (Schraders
et al. 2010); how this mutation affects PTPRQ function is not
yet known.
Although LET-805 has the structure of a cell-surface re-
ceptor protein, it has been unclear whether it interacts with
specific ligands, or whether such an interaction might affect
intracellular signals. Our identification of the cluster of gain-
of-function mutations in the ECD as suppressors of BM mu-
tant defects might suggest that this region of LET-805 directly
interacts with one or more BM proteins. Our suppression
analysis indicates that the let-805 suppressors can suppress
phenotypes due to loss of function in multiple BM proteins,
but do not suppress null mutations in certain structural BM
components. This pattern of suppression argues against a
Figure 6 Localization of LET-805::
GFP knock-ins. In late-stage em-
bryos from (A) wild-type, (B) let-
805(ju1123), and (C) larval animals,
LET-805::GFP localizes to epider-
mal attachment structures overly-
ing body wall muscles and (D) to
the uterine seam. In embryos, LET-
805::GFP localization in let-805
suppressor mutant backgrounds
resembled that of the wild-type
LET-805::GFP; in adults mutant
for suppressor alleles let-805
(ju1123), let-805(ju1165), and let-
805(ju1184), LET-805::GFP dis-
plays increased aggregates along
the mid-body (E) (arrowheads). (F)
Quantitation of aggregation as de-
scribed in Materials and Methods;
significance, t-test, ** P , 0.01,
*** P , 0.001.
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direct interaction mechanism, but is more consistent with
bypass suppression in which the functional requirement for
certain BM proteins has been relieved.
We consider two generalmodels for how thismight occur,
although these are notmutually exclusive. In thefirstmodel,
the gain of functionmutations cause suppression by altering
or enhancing interactions with specific ligand(s). Although
binding partners for the LET-805 ECD are not known, can-
didates include BM components such as those identified as
suppressors in our screen. The clustering of the LET-805
suppressors suggests that they could affect a single binding
interaction. Additionally, the aggregation observed in LET-
805::GFP could indicate an increased binding affinity of
the mutant protein for a ligand. The second model is that
the gain-of-function mutations promote BM or epidermal
function more indirectly, independent of a specific ligand
interaction, possibly by stabilizing a specific conformation
of LET-805 that enhances its signaling activity. The mecha-
nism of LET-805 activation or regulation is not understood
but might involve lateral associations, mediated by its ECD,
to form dimeric or higher-order complexes, analogous to
other transmembrane receptors. Fibronectin is known in-
teract homophilically, and its FNIII repeats have been hy-
pothesized to be important for forming networks in the
extracellular matrix (Ingham et al. 1997). The aggregation
of LET-805::GFP might reflect analogous increased self-
association into higher-order complexes. It remains to be
elucidated whether or how LET-805 might signal into cells;
it contains a small, highly disordered intracellular domain of
unknown function.
Mechanism of suppression by mutations in perlecan
The third major locus identified in our suppressor screen is
unc-52/perlecan, a key conserved molecule in metazoan
BMs. Perlecan is a large multidomain HSPG linked to many
developmental and physiological processes (Gubbiotti et al.
2017). The five major domains of perlecan all likely function
in protein–protein interactions (Iozzo 2005), and the mis-
sense mutations identified here could alter affinity of perle-
can for specific BM proteins. C. elegansUNC-52 is essential for
embryonic development, although it does not appear to be a
generic BM component, and it remains unclear if UNC-52 is
heparan sulfated. Perlecan incorporation into BMs is thought
to be dependent on type IV collagen; genetic analysis has
suggested that perlecan can antagonize the function of type
IV collagen in the Drosophila BM (Pastor-Pareja and Xu
2011). Perlecan and type IV collagen also have antagonistic
roles in C. elegans synaptic growth (Qin et al. 2014). These
observations suggest that the suppressor mutations identified
here may not all cause a gain of function, but might weakly
reduce function of perlecan.
In summary, we have found that putative gain-of-func-
tion alterations in a variety of genes are capable of suppress-
ing profound defects in BM function. These observations
suggest that although BM proteins such as SPON-1 and
PXN-2 are required for viability in C. elegans, they are not
essential for BM formation. Conversely, genetic suppres-
sor analysis suggests that other proteins, such as type IV
collagen or perlecan, are essential for BM structure and
cannot be bypassed, although partial loss-of-function or
hypomorphic alleles of such structural BM components
can be bypassed. Although the mechanistic basis of the
phenotypic suppression remains to be fully explored,
our results suggest unexpected levels of flexibility in the
genetic requirements for BM function. It would be inter-
esting to explore if comparable compensatory interactions
might occur in the BMs of other species.
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Figure 7 Suppression of BM phenotypes by missense
alterations in unc-52 perlecan. (A) Domain structure of
UNC-52 (A isoform) and locations of mutations and
amino acid substitutions. (B) unc-52 suppressor alleles
suppress pxn-2(tm3464) and spon-1(ju430) lethality,
and weakly suppress emb-9(b189ts) lethality. LDLR,
low-density lipoprotein receptor class A repeat; EGF,
Laminin EGF-like domain; Lam B, Laminin B domain.
Results of Student’s t-test for percent total lethality
(sum of embryonic and larval lethality). ** P , 0.01,
*** P , 0.001.
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